OVERVIEW

3rd Annual MarketsandMarkets High Potent Medicines Conference is organized by Markets and Markets (MnM) Conferences and will be held from May 28 - 29, 2019 at Milan, Lombardia, Italy.

Who should attend:
From pharmaceutical manufacturing and Biopharmaceutical manufacturing:
• Chief executives
• VP’s
• Directors
• Heads
• Leaders
• Senior Managers
• Principal Scientists
• Principal Toxicologists
• Toxicologists
• Fellows.
Investigators working in the following departments:
• Research & Development
• Manufacturing/Operations/Production
• Maintenance
• Engineering
• Quality
• Regulatory
• Risk Assessments
• Laboratory Services/Analytical
• New Technologies
• Process Development/Technical transfer
• Environmental, Health & Safety (HSE)
• Occupational Toxicology
• Industrial Hygiene
• New Products
• Product Quality
• Innovations
• Regulatory
• Validation
• Formulation Development
• External Supply

Event Overview:
The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.

Drug product development for highly potent APIs (HPAPIs) can be challenging. Complications with the interface between operations in drug substance and drug product handling can result in increased program complexity and cost. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

The conference will focus on case studies related to development, rapid scaling, validation and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product. The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breathrough panel sessions.

Key Highlights:
• Process validation considerations and scale-up in high potent compounds production
• Strategies for effective management of high potent medicines supply chain
• Overcoming regulatory challenges for ADC’s
• Validation of cleaning procedures to avoid cross contamination
• Containment and safety of pharmaceutical toxic powders
• Managing cleaning validation in biologics
• Risk identification and mitigation for HPAPI’s